Avastin® (bevacizumab) is approved to treat glioblastoma (GBM) in adult patients whose cancer has progressed after prior treatment (recurrent or rGBM).
In a clinical study, when people with recurrent glioblastoma took Avastin with chemotherapy (lomustine) instead of chemotherapy alone:
In a rGBM trial, all side effects were collected for people taking Avastin with lomustine or lomustine alone. Serious to life threatening blood clots in the veins of the body were seen in 5% of patients receiving Avastin with chemotherapy compared to 2% of patients receiving chemotherapy alone. In this study, 22% of people who took Avastin with lomustine stopped treatment compared to 10% of people who took lomustine alone. The side effects found in people taking Avastin and lomustine are similar to other trials.
Talk to your doctor about the benefits and risks of Avastin. To learn about the possible side effects of taking Avastin, visit the Side Effects page.
Questions about Avastin treatment costs? Let us help you understand your financial assistance options.
Avastin is a tumor-starving therapy. Read more about how it's designed to work.
Find helpful information and support.
The information contained in this section of the site is intended for U.S. healthcare professionals only. Click "OK" if you are a healthcare professional.
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to the terms and conditions of use for such sites.